- Pharmaceutical companies
- Viatris
Viatris
Phone: +17245141800
Type | Public |
---|---|
Traded as |
|
ISIN | US92556V1061 |
Industry |
|
Predecessors |
|
Founded | November 16, 2020 (2020-11-16) |
Headquarters | Canonsburg, Pennsylvania, U.S. |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$17.89 billion (2021) |
Net income | US$−1.27 billion (2021) |
Total assets | US$54.84 billion (2021) |
Total equity | US$20.49 billion (2021) |
Number of employees | c. 37,000 (December 2021) |
Website | viatris.com |
At Viatris, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.
For detailed contact information visit location pages below.
Viatris's locations around the world
Europe
North America
South America
Oceania
Clinical Trials sponsored by Viatris
-
Viatris KoreaWervingPerifere neuropathische pijnKorea, republiek van
-
Viatris Specialty LLCVoltooid
-
Viatris Specialty LLCVoltooidMisbruik PotentieelVerenigde Staten
-
Viatris Specialty LLCVoltooidMisbruik PotentieelVerenigde Staten
-
Viatris Inc.WervingAnticonceptieDuitsland
-
Viatris Pharmaceuticals Japan IncVoltooidPulmonale arteriële hypertensieJapan
-
Viatris Inc.Nog niet aan het wervenBio-equivalentieonderzoekThailand
-
Viatris Inc.Nog niet aan het werven
-
MEDA PHARMA SPA, a Viatris companyNog niet aan het werven
-
Theravance BiopharmaViatris Inc.VoltooidChronische obstructieve longziekteVerenigde Staten